In 2012, Kevin W. Sharer earned $6.18M in total compensation at Amgen, including $1.81M salary and $3.02M in stock. Most recently sold 6,562 shares in Mar 2014. Currently holds stock worth $26.26M. Has donated $427.69M in stock to charitable causes. Led Amgen as CEO for 12 years.
Compensation History
Annual executive compensation data for Kevin W. Sharer, including salary, bonuses, and stock awards.
Year
2012
Total Compensation
$6.18M
Salary
$1.81M
Bonus
$0.00
Other
$1.36M
Salary
$1.81MBoard Justification
The compensation philosophy is designed to align executive compensation with company performance and market benchmarks, targeting the median of peer group compensation.
Bonus
$0.00Board Justification
Pro-rata portion of annual CEO cash incentive award earned for 2012, reflecting service through May 2012.
Other Compensation
$1.36MBoard Justification
Includes perquisites and other compensation such as secretarial, information technology and travel support provided until December 31, 2017.
Restricted Stock
Board Justification
Value of performance units and RSUs granted during 2012, based on actual performance and vesting conditions met.
Performance Metrics
Performance metrics for 2012 included revenue growth, adjusted net income, and total shareholder return compared to peers.
Kevin W. Sharer
Ex-CEO of Amgen
Education
Bachelor's degree from the University of California, Santa Barbara and an MBA from the University of California, Los Angeles.
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
November 26, 1951 - 74 years ago
CEO of Amgen for
12 years 0 months (May 2000 - May 2012)
Previous Experience
President and Chief Operating Officer at Amgen
Other Amgen CEOs
Holdings
Track Kevin W. Sharer's stock holdings and portfolio value over time.
Total Stock Sold
$113.93M
$113.12M
1,475,550 AMGN shares
$805.29K
6,562 NOC shares
What if they kept their stock?
If Kevin W. Sharer didn't sell their stock, today they would have:
Extra AMGN1,475,550 shares worth $486.77M and NOC6,562 shares worth $3.60M.
This is 330.43% and $376.45M more than what they got when they sold the stock.
Charitable Transactions
1,296,460 shares
AMGN
Recent Charitable Transactions
Insider Trading
Kevin W. Sharer's recent stock transactions, purchases, and sales filed with the SEC.
$804.72K
NOC at $122.63/share
Mar 10, 2014
Sale
Rivals
Compare Kevin W. Sharer with competitor CEOs and industry peers.
Albert Bourla
CEO of Pfizer
2024 Compensation
Stock
$0.00
Salary
$1.80M
Bonus
$7.02M
Other
$996.06K
Total Holdings
$18.14M
Daniel O'Day
CEO of Gilead Sciences
2024 Compensation
Stock
$18.79M
Salary
$1.77M
Bonus
$0.00
Other
$1.34M
Total Holdings
$23.48M
Robert M. Davis
CEO of Merck & Co.
2024 Compensation
Stock
$18.10M
Salary
$1.62M
Bonus
$0.00
Other
$561.11K
Total Holdings
$43.45M
Joaquin Duato
CEO of Johnson & Johnson
2024 Compensation
Stock
$7.13M
Salary
$1.60M
Bonus
$3.22M
Other
$1.08M
Total Holdings
$1.09M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M
Christopher Boerner
CEO of Bristol-Myers Squibb
2023 Compensation
Stock
$0.00
Salary
$1.50M
Bonus
$0.00
Other
$311.64K
Total Holdings
$7.39M